According to a Vertex spokesperson, the drug is seeing strong initial market adoption, with growing payer coverage and ...

Thryv Therapeutics Inc., a clinical-stage biotechnology company pioneering novel therapies for cardiovascular diseases, is pleased to announce its participation in the 2025 Piper Sandler Virtual ...

"I wanted to create something that not only alleviates physical pain but also brings a sense of comfort and joy to children during what can be a distressing time," said an inventor, from Gallatin, ...

Crown Laboratories, Inc. ("Crown"), a fully integrated global skincare company, is excited to announce the launch of Sarna® Eczema Relief Skin Protectant Lotion. Building on its reputation as the #1 ...

In the Japanese Phase 3 study, 0% mortality was reported over the 30-month treatment period and acoramidis was well-toleratedThe approval was ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals ...

MELVILLE, N.Y., March 27, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. ("BioRestorative”, "BRTX” or the "Company”) ...

"As a cancer patient, having options to manage the side effects of life saving drugs is very important. I believe the published results of crofelemer for the prophylaxis of CTD are very exciting and ...

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...

Certain widely used drug combinations may either slow down or worsen the progression of Alzheimer's disease, but their ...